Dilon Technologies Announces FDA Approval and U.S. Launch of MarginProbe® 2, Next-Generation Intraoperative margin assessment technology [Yahoo! Finance]
HCA Healthcare (NYSE:HCA) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.
HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 86% Above Its Share Price [Yahoo! Finance]
HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Robert W. Baird from $423.00 to $450.00. They now have a "neutral" rating on the stock.
L1 Capital International Trimmed HCA Healthcare (HCA) Following Share Price Appreciation [Yahoo! Finance]